Injectoplast Profile
Key Indicators
- Authorised Capital ₹ 3.25 Cr
- Paid Up Capital ₹ 3.20 Cr
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 30.46 Cr
- Revenue Growth %
- Profit Growth 90.66%
- Ebitda 97.39%
- Net Worth -12.30%
- Total Assets -38.57%
About Injectoplast
Injectoplast Private Limited (IPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 September 2020 (Four years and five months 8 days old ). Its registered office is in Kanpur Nagar, Uttar Pradesh, India.
The Company is engaged in the Automotive Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.25 Cr and a paid-up capital of Rs 3.20 Cr.
The company currently has active open charges totaling ₹30.46 Cr.
Ram Shah, Arun Shah, Abhishek Shah, and Three other members serve as directors at the Company.
Company Details
- Location
Kanpur Nagar, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U25209UP2020PTC134607
- Company No.
134607
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Sep 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Injectoplast?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Shah  | Managing Director | 14-Sep-2020 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ayush Pandey | Director | 27-Mar-2023 | Current |
| Abhishek Shah | Director | 28-Jun-2023 | Current |
| Ram Shah | Director | 17-Jan-2023 | Current |
| Akshay Bajaj | Additional Director | 01-Aug-2024 | Current |
| Devansh Bajaj | Additional Director | 01-Aug-2024 | Current |
Financial Performance of Injectoplast.
Injectoplast Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 90.66% increase in profit. The company's net worth observed a substantial decline by a decrease of 12.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Injectoplast?
In 2022, Injectoplast had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lohia Mechatronik Private LimitedAyush Pandey is a mutual person
Plastica Trading Private LimitedArun Shah is a mutual person
Ip Plastotech Private LimitedArun Shah is a mutual person
- Abhishek Finsec Private Limited
Arun Shah and Abhishek Shah are mutual person
- Novus Plastotech Private Limited
Abhishek Shah is a mutual person
- Injecto Innovations Private Limited
Abhishek Shah is a mutual person
Charges (Loans)
₹30.46 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 15.46 Cr
- Axis Bank Limited : 15.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Oct 2024 | Others | ₹4.58 M | Open |
| 07 Jul 2024 | Others | ₹15.00 Cr | Open |
| 02 Jan 2024 | Axis Bank Limited | ₹15.00 Cr | Open |
How Many Employees Work at Injectoplast?
Injectoplast has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Injectoplast, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Injectoplast's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
